COF

Capital One

$178.66

-1.71%
Nov 20, 2026
Bobby Quantitative Model
Capital One Financial is a diversified financial services holding company whose core business is credit card lending, supplemented by auto loans, commercial lending, and a modest personal loan book, operating in the U.S. consumer and commercial banking industry. The company is a top-tier card issuer and, following its 2025 acquisition of Discover Financial, has become a scaled payments-and-lending platform that combines a proprietary card network with a large deposit franchise, distinguishing it from pure-play card lenders. The current investor narrative centers on the Discover integration — management is realizing cost and revenue synergies faster than expected, which bulls argue will materially lift earnings power by 2027, while bears point to messy reported results, elevated acquisition-related expenses, and a sharp year-to-date stock decline. Recent coverage highlights a strong Q3 EPS beat alongside cautious commentary on stock underperformance, and the debate now hinges on whether synergy capture and improving credit quality can re-rate a stock that has badly lagged the market.

People also watch

Visa Inc.

Visa Inc.

V

Analysis
Mastercard

Mastercard

MA

Analysis
American Express

American Express

AXP

Analysis
PayPal Holdings

PayPal Holdings

PYPL

Analysis
Global Payments

Global Payments

GPN

Analysis

BobbyInvestment Opinion: Should I buy COF Today?

Rating: Buy (moderate conviction). The thesis is that Capital One is a scaled card-and-payments franchise trading at 8.18x the $34.14 consensus forward EPS — an earnings yield of roughly 12.2% — while quarterly EPS has accelerated from $3.34 (Q1 2026) to $4.73 (Q2) to $5.62 (Q3) and the sell-side consensus sits at Buy (19 Buy / 4 Hold / 0 Sell, mean 1.57) with a $254.48 average target implying 30.4% upside from $195.08. In short, the fundamentals are inflecting faster than the share price, which is down 21.32% YTD.

The supporting evidence is unusually concrete for a value setup: gross margin expanded from 57.79% in Q1 2026 to 65.96% in Q3, operating margin from 13.97% to 22.46%, and Q3 EPS beat consensus by 22.75%. Trailing free cash flow is $26.25 billion, Q3 alone produced $5.32 billion of FCF, and the company returned $2.684 billion in buybacks plus $547 million in dividends while cutting share count from 639 million to 608.9 million year-over-year. Valuation is undemanding on every balance-sheet metric — 1.15x book (mid-range of its historical 0.67x–1.35x band), 1.89x sales near the low end of its multi-year range, and debt-to-equity of just 0.449 — and even the lowest analyst target of $225 sits 15.3% above the current price.

The risks that could invalidate this view are (1) consumer credit deterioration — subprime auto delinquencies are at a 32-year high and a provision build would compress the margins driving the beat; (2) slower-than-expected Discover synergy capture, which would undermine the $34.14 forward EPS that the entire thesis rests on, especially with revenue growing only 2.69% year-over-year; and (3) a persistent value-trap dynamic in which the 8.18x multiple stays cheap because the market distrusts the estimate. This Buy would upgrade to high conviction if the stock reclaims the $210–$225 resistance zone on a clean Q4 beat, and would downgrade to Hold if price breaks the $174.24 52-week low or if forward EPS estimates are cut below roughly $30. Verdict: undervalued relative to its own history and to the demonstrated margin recovery — but the discount is a bet on execution, not a free lunch.

Sign up to view all

COF 12-Month Price Forecast

The forward-looking case is that Capital One's earnings power is inflecting well ahead of its share price: an 8.18x forward multiple on $34.14 of estimated EPS is a ~12.2% earnings yield for a franchise that now owns a proprietary card network, and the quarterly EPS and margin progression shows the Discover synergies are already flowing through. The main reason confidence is medium rather than high is that the thesis leans on margin expansion rather than revenue — top-line growth is only 2.69% year-over-year — and the stock's 21.32% YTD decline, -31.94 relative strength versus the S&P 500, and position at just 24.4% of its 52-week range mean the market has not yet validated the recovery. Consumer credit is the swing variable: subprime auto delinquencies at a 32-year high could force provisions that erase the margin gains. I would upgrade to high confidence if Q4 delivers another beat with forward EPS guidance at or above $34.14 and the stock clears the $210–$225 resistance zone; I would downgrade to neutral if price breaks the $174.24 low or if consensus EPS is cut below roughly $30.

Historical Price
Current Price $178.66
Average Target $239.74
High Target $290.00
Low Target $174.24

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Capital One's 12-month outlook, with a consensus price target around $254.48 and implied upside of +42.4% versus the current price.

Average Target

$254.48

23 analysts

Implied Upside

+42.4%

vs. current price

Analyst Count

23

covering this stock

Price Range

$225 - $290

Analyst target range

Buy
20 (87%)
Hold
3 (13%)
Sell
0 (0%)

Coverage is broad and overwhelmingly bullish: 21 analysts rate the stock, with 19 Buy, 4 Hold, and 0 Sell, yielding a consensus recommendation of "buy" and a recommendation mean of 1.57 (where 1.0 is a strong buy). The average target price of $254.48 implies roughly 30.4% upside from the current $195.08, a substantial gap that underscores how disconnected the sell-side view is from the market's recent pessimism. The consensus clearly leans bullish, and the absence of any sell ratings despite a 21% YTD decline suggests analysts view the weakness as a temporary dislocation rather than a fundamental deterioration.

The target range of $225.00 to $290.00 is wide — a 28.9% spread from low to high — signaling meaningful uncertainty about the pace of Discover synergy realization and credit normalization. The high target of $290 (48.7% upside) likely assumes full synergy capture, multiple expansion toward book-value-plus, and continued EPS beats toward the $34.14 consensus estimate; the low target of $225 (15.3% upside) still implies gains but prices in slower integration, margin compression, or a tougher consumer credit environment. Institutional ratings show a steady stream of reiterations — UBS, Piper Sandler, TD Cowen, Barclays, Citigroup, JP Morgan, Morgan Stanley, and BMO all maintained Buy/Overweight or Market Perform ratings through October and November 2026 — with no downgrades, indicating stable conviction. The wide spread and unanimous bullish tilt suggest high-conviction but high-variance expectations, making execution on the Discover integration the single most important swing factor for the stock.

Drowning in data?

Find the real signal!

Bulls vs Bears: COF Investment Factors

The bull case currently holds the stronger evidence: a forward PE of 8.18x against a 22.75% Q3 EPS beat, expanding gross margins (57.79% to 65.96% across 2026), $26.25 billion in trailing free cash flow, and unanimous sell-side support with a $254.48 average target implying 30.4% upside. The bear case rests largely on price action — a 21.32% YTD decline, -31.94 relative strength, and a stock sitting in the lower quartile of its 52-week range — plus messy trailing GAAP metrics distorted by the 2025 loss quarter and genuine consumer-credit risk. The single most important tension is whether Discover synergy capture and margin expansion translate into the $34.14 forward EPS the market is being asked to believe; if it does, the 8.18x multiple is a glaring discount, but if credit deteriorates or integration benefits slip, the cheap multiple is a value trap. Fundamentally the fundamentals are inflecting faster than the stock, but the broken technical trend means the market has not yet voted confidence.

Bullish

  • Forward PE of 8.18x is deeply discounted: At $195.08, COF trades at just 8.18x the $34.14 consensus EPS estimate, an earnings yield of roughly 12.2% versus a 1.35% dividend yield. That multiple is at the low end of what scaled card issuers command and sits far below the trailing 60.14x, which is distorted by the Q2 2025 loss quarter. The market is pricing heavy skepticism that the forward estimate can be delivered.
  • EPS acceleration is sharp and consistent: Quarterly EPS climbed from $3.34 in Q1 2026 to $4.73 in Q2 and $5.62 in Q3, a 68% sequential increase over two quarters, with Q3 beating consensus by 22.75%. Gross margin expanded from 57.79% in Q1 to 65.96% in Q3, and operating margin rose from 13.97% to 22.46% over the same span. This is a clear earnings inflection, not a one-off.
  • Unanimous sell-side conviction, 30% upside: All 21 covering analysts rate COF Buy or Hold with zero Sell ratings, a recommendation mean of 1.57, and an average target of $254.48 implying 30.4% upside from $195.08. Even the lowest target of $225 implies 15.3% upside, meaning the entire published range sits above the current price. Eight-plus institutions reiterated Buy/Overweight through October and November 2026 with no downgrades.
  • Discover synergies are beating expectations: Management is realizing cost and revenue synergies faster than expected, with interchange fees of $2.335 billion and service charges of $236 million now contributing to Q3 revenue of $20.357 billion. Commentary suggests the integration could boost earnings by roughly 15% by 2027, a tailwind the current 1.15x book multiple appears not to reflect. This is the core of the re-rating thesis.

Bearish

  • Stock is in a broken downtrend: COF is down 21.32% YTD and 10.02% over one year versus the S&P 500's +10.62% and +12.27%, a relative strength gap of -31.94 and -22.29 respectively. At $195.08 the stock sits at only 24.4% of its $174.24–$259.64 52-week range, in the lower quartile, with a 31.73% max drawdown. The burden of proof is squarely on the bulls to reclaim lost ground.
  • Reported results remain messy: The trailing PE of 60.14x and trailing ROE of 2.16% still absorb the Q2 2025 loss of -$4.277 billion (-26.06% net margin) tied to acquisition charges. Net margin on a trailing basis is just 3.54% and operating margin 3.29%, far below the Q3 run-rate, meaning headline profitability metrics look poor until the loss quarter rolls off. This keeps valuation screens and some quantitative buyers sidelined.
  • Revenue growth is modest for the multiple: Q3 2026 revenue of $20.357 billion grew only 2.69% year-over-year, and the sequential climb from $19.317 billion in Q1 is gradual. The investment case therefore leans almost entirely on synergy-driven margin expansion rather than top-line momentum, leaving little cushion if integration benefits slip. A 2.69% grower must prove it deserves re-rating.
  • Consumer credit and subprime exposure: Subprime auto delinquencies recently hit their worst rate in 32 years, a direct threat to COF's auto and card books given its consumer-lending focus. A deteriorating credit environment would force higher provisions, compressing the very margins that drove the Q3 beat. This is the key exogenous risk that could invalidate the forward EPS estimate.

COF Technical Analysis

COF is in a choppy, range-bound consolidation with a distinctly negative longer-term tilt: the stock is down 10.02% over the past year and 21.32% year-to-date, a stark underperformance versus the S&P 500's +12.27% one-year and +10.62% YTD returns (relative strength of -22.29 and -31.94, respectively). At $195.08, the stock sits at roughly 24.4% of its 52-week range of $174.24–$259.64, meaning it is trading in the lower quartile — closer to the lows than the highs, which signals a broken uptrend rather than momentum leadership. The 31.73% max drawdown confirms this is a recovery-or-repair setup, not a stock riding near highs, and the burden of proof sits with the bulls to reclaim lost ground.

Short-term momentum is stabilizing but not yet convincing. The stock is up 0.38% over one month and 4.23% over six months, yet down 14.19% over three months, a pattern of a sharp mid-summer-to-fall decline followed by a modest bounce. Notably, the one-month relative strength of +2.64 versus SPY's -2.26% shows COF outperforming a weak tape recently, hinting at early mean-reversion interest, though the three-month relative strength of -11.36 confirms the intermediate trend remains negative. The divergence — positive 1-month and 6-month returns against a negative 1-year and 3-month picture — is characteristic of a bottoming attempt within a larger downtrend, and the 1.83 short ratio suggests short sellers are not aggressively pressing, leaving room for a squeeze if fundamentals cooperate.

Key technical levels are well defined. Support sits at the 52-week low of $174.24, roughly 10.7% below the current $195.08; a breakdown there would signal capitulation and likely open a deeper leg lower, while resistance at the $259.64 52-week high is a distant 33.1% above and would require a full trend reversal to challenge. More immediately, the stock must clear the $210–$225 zone where it repeatedly stalled in August and October before the high becomes relevant. With a beta of 1.088, COF is only modestly more volatile than the market — about 9% — so position sizing need not be dramatically reduced, but the wide 52-week range and 31.73% drawdown argue for disciplined stop placement near the $174 support.

Beta

1.09

1.09x market volatility

Max Drawdown

-31.7%

Largest decline past year

52-Week Range

$174-$260

Price range past year

Annual Return

-11.7%

Cumulative gain past year

PeriodCOF ReturnS&P 500
1m-13.5%-9.7%
3m-18.0%-9.9%
6m-4.9%-7.5%
1y-11.7%+4.7%
ytd-27.9%+1.2%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

COF Fundamental Analysis

Revenue is growing modestly and steadily, with Q3 2026 revenue of $20.357 billion up 2.69% year-over-year from $19.823 billion in Q3 2025, extending a multi-quarter climb from $19.317 billion in Q1 2026 and $19.861 billion in Q2 2026. The sequential trajectory ($19.32B → $19.86B → $20.36B) shows consistent top-line expansion, and the year-over-year comparison is flattered by the Discover consolidation that has scaled the balance sheet. Segment data shows interchange fees of $2.335 billion and service charges of $236 million contributing meaningfully, reflecting the payments-network economics the Discover deal unlocked. Growth is real but modest for a company trading at a premium book multiple, so the investment case leans heavily on synergy-driven earnings acceleration rather than raw revenue momentum.

Profitability has inflected sharply upward. Q3 2026 net income was $3.539 billion with a 17.38% net margin, a dramatic recovery from the Q2 2025 loss of -$4.277 billion (a -26.06% net margin) driven by acquisition-related charges. Gross margin in Q3 2026 was 65.96%, up from 57.79% in Q1 2026 and 57.36% in Q4 2025, while operating margin reached 22.46% versus 13.97% in Q1 2026. The EPS progression tells the story: $3.34 (Q1) → $4.73 (Q2) → $5.62 (Q3), a clear acceleration that beat consensus by 22.75%. Margins are now in line with or above historical norms for large card issuers, and the trend is expansionary rather than compressing.

Balance sheet and cash generation are solid for a bank. Debt-to-equity is a conservative 0.449, and free cash flow TTM is a robust $26.254 billion, with Q3 2026 FCF of $5.32 billion on operating cash flow of $5.712 billion. ROE of 2.16% and ROA of 1.57% look low on a trailing basis because they still absorb the 2025 loss quarter, but the quarterly historical ratios show ROE recovering to 3.23% in Q3 2026 from negative territory in mid-2025. The company returned capital aggressively — $2.684 billion in buybacks and $547 million in dividends in Q3 alone — and holds $49.331 billion in cash, indicating it funds growth internally rather than depending on external financing. The current ratio of 0.146 reflects the bank's liability-heavy structure and is not a liquidity red flag in this industry context.

Quarterly Revenue

$20.4B

2026-09

Revenue YoY Growth

+2.7%

YoY Comparison

Gross Margin

66.0%

Latest Quarter

Free Cash Flow

$26.3B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Other Contract Revenue
Interchange Fees, Contracts
Service Charges And Other Customer Fees, Contracts

Open an Account, get $2 TSLA now!

Valuation Analysis: Is COF Overvalued?

Because net income is positive ($3.539 billion in Q3 2026), the PE ratio is the appropriate primary metric. The trailing PE of 60.14x looks alarming but is distorted by the trailing-twelve-month period that still includes the Q2 2025 loss; the forward PE of 8.18x is the far more meaningful figure, and the enormous gap between trailing and forward multiples implies the market expects earnings to normalize dramatically as Discover synergies flow through. That 8.18x forward multiple on estimated EPS of $34.14 is remarkably cheap for a franchise with a proprietary payments network, and the gap itself is the core of the bull thesis.

Against the credit-services industry, COF's forward PE of 8.18x and price-to-book of 1.15x sit at the low end of what scaled card issuers command, while the PS ratio of 1.89x and EV/EBITDA of 16.52x reflect the balance-sheet-heavy nature of the business. The PEG ratio of -0.92 is not meaningful given the earnings distortion, but the forward earnings yield of roughly 12.2% (1/8.18) versus a 1.35% dividend yield signals the market is pricing significant skepticism. The discount appears unjustified relative to the demonstrated margin recovery and synergy capture, suggesting either a value opportunity or a market that doubts the sustainability of forward estimates.

Historically, COF's PE has ranged widely — from roughly 5x in 2022–2023 to over 18x in Q4 2025 — and the current trailing 60x is an artifact of the loss quarter, not a true historical high. More telling is the price-to-book: 1.15x today versus a historical band of roughly 0.67x–1.35x over the past several years, placing it in the middle of its own range. The PS ratio of 1.89x is near the low end of its multi-year range (which peaked above 7x in late 2025 on depressed revenue), reinforcing that the stock is not priced for optimism. The market is assigning a mid-range book multiple to a company with recovering margins — a setup that offers asymmetric upside if synergy delivery continues.

PE

60.1x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 5x~20x

vs. Industry Avg

14.2x

Industry PE ~14.2x*

EV/EBITDA

16.5x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks center on the still-unproven earnings normalization embedded in the forward estimate. The trailing PE of 60.14x, trailing net margin of 3.54%, and trailing ROE of 2.16% all still absorb the Q2 2025 loss of -$4.277 billion, so reported profitability looks weak until that quarter rolls off, and the entire bull case depends on delivering $34.14 in forward EPS versus a $5.62 Q3 run-rate that must be sustained and grown. Revenue growth of just 2.69% year-over-year provides a thin organic cushion, meaning margin expansion from Discover synergies — not top-line momentum — must do the heavy lifting. The current ratio of 0.146 reflects the bank's liability-heavy structure and is normal for the industry, but it underscores that liquidity depends on deposit and funding-market confidence rather than a liquid asset buffer.

Market and competitive risks are dominated by valuation compression and consumer-credit deterioration. At 1.15x book and 8.18x forward earnings, COF is not priced for optimism, but that also means the discount could persist if the market doubts forward estimates — a value trap rather than a mispricing. Subprime auto delinquencies hitting a 32-year high directly threaten COF's auto and card books, and any provision build would compress the margins that drove the Q3 beat. With a beta of 1.088, COF carries roughly 9% more volatility than the market, so a broad risk-off rotation or financials selloff would hit it modestly harder than the index, and the -31.94 YTD relative strength gap versus the S&P 500 shows the stock has already been on the wrong side of sector rotation.

The worst-case scenario is a credit cycle turn coinciding with slower-than-expected synergy realization: provisions rise, the $34.14 forward EPS estimate gets cut, and the 8.18x multiple proves justified rather than cheap, driving the stock toward its 52-week low of $174.24 — roughly 10.7% below the current $195.08. A break of that support would signal capitulation and likely open a deeper leg lower, and the 31.73% max drawdown shows the stock has already demonstrated it can fall that far. In a more severe scenario where the low fails, an investor could realistically lose 15–25% from current levels, with the analyst low target of $225 offering no downside protection since it sits above the current price. Disciplined stop placement near the $174 support is the practical risk-management response.

FAQ

The most severe risk is consumer credit: subprime auto delinquencies at a 32-year high threaten the card and auto books, and a provision build would compress the 65.96% gross margin that drove the 22.75% Q3 EPS beat. Second is execution on the Discover integration — with revenue growing only 2.69% year-over-year, the entire $34.14 forward EPS estimate rests on synergy capture, and any slippage would leave the 8.18x multiple looking justified rather than cheap. Third is valuation and sentiment persistence: a 21.32% YTD decline, -31.94 relative strength versus the S&P 500, and a stock at 24.4% of its 52-week range show the market has not validated the recovery, and a value trap could keep the discount in place. Fourth is market sensitivity — a beta of 1.088 means a broad financials selloff or risk-off rotation hits COF about 9% harder than the index, with the $174.24 low as the realistic downside marker.

The 12-month view splits into three scenarios. The base case (50% probability) targets $225–$254.48, assuming $34.14 forward EPS is broadly delivered, gross margin holds near 65.96%, and the multiple stays compressed at 7–9x forward. The bull case (30%) targets $254.48–$290, requiring Discover synergies at or above the ~15% 2027 earnings uplift, stabilizing credit, and re-rating toward the low-to-mid teens on forward earnings. The bear case (20%) targets $174.24–$225, driven by a credit turn that forces provisions, cuts the forward EPS estimate, and retests the 52-week low. The base case is most likely, and its key assumption is that the $5.62 Q3 EPS run-rate is sustained without a material provision build — the analyst average of $254.48 implies 30.4% upside from $195.08.

The primary metric is the forward PE of 8.18x on $34.14 of estimated EPS, which is cheap for a scaled card issuer with a proprietary payments network and implies an earnings yield of about 12.2%. The trailing PE of 60.14x is misleading because it still absorbs the Q2 2025 loss of -$4.277 billion, so the gap between trailing and forward multiples is itself the market's statement that earnings are normalizing. On book value, the 1.15x price-to-book sits mid-range within a historical band of roughly 0.67x–1.35x, and the 1.89x price-to-sales is near the low end of its multi-year range. The market is therefore paying a fair-to-discounted price that embeds skepticism about the forward estimate rather than optimism — undervalued if synergy delivery continues, fairly valued if credit costs rise.

From a risk/reward standpoint the setup is asymmetric but conditional. The stock trades at $195.08 against a $254.48 average analyst target — 30.4% upside — and even the lowest of the 21 published targets, $225, sits 15.3% above the current price, with 19 Buy ratings and zero Sells. The downside is defined by the $174.24 52-week low, about 10.7% below the current price, so the reward-to-risk skew is roughly 3:1 on published targets. The catch is that the upside depends on delivering $34.14 of forward EPS, which requires sustaining and growing the $5.62 Q3 run-rate while subprime auto delinquencies sit at a 32-year high. It is a good buy for value-oriented investors with a 12–18 month horizon who can stomach a beta of 1.088 and a 31.73% historical drawdown; it is a poor fit for anyone needing near-term momentum or low volatility.

COF is better suited to a long-term hold than a short-term trade. It is a post-merger integration story whose payoff — the roughly 15% earnings uplift targeted for 2027 — plays out over multiple quarters, and the stock's 31.73% max drawdown, 28.9% analyst target spread, and 1.83 short ratio make near-term price action highly unpredictable. The 1.35% dividend yield with a 72.08% payout ratio offers little income support, so returns depend on multiple re-rating and EPS delivery rather than cash distributions. Earnings visibility is improving — EPS rose from $3.34 to $4.73 to $5.62 across 2026 — but remains hostage to consumer credit, which argues for patience. A minimum holding period of 12–18 months is appropriate, long enough to capture at least two more earnings cycles and the 2027 synergy realization, with a stop near the $174.24 support to cap downside.